Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pim J French

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Cancers|December 3, 2020
Beyond the Influence of <i>IDH</i> Mutations: Exploring Epigenetic Vulnerabilities in ChondrosarcomaSanne Venneker, Alwine B Kruisselbrink, Zuzanna Baranski, et al.
The Prostate|April 25, 2019
A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signalingJan M Moll, Jinpei Kumagai, Martin E van Royen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2006
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatmentMathilde C M Kouwenhoven, Johan M Kros, Pim J French, et al.
Cancer Research|June 19, 2007
Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arraysPim J French, Justine Peeters, Sebastiaan Horsman, et al.
Scientific Reports|February 21, 2020
Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumorsAzadeh Amirnasr, Robert M Verdijk, Patricia F van Kuijk, et al.
Acta Neuropathologica Communications|November 25, 2018
Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnosticsNathalie E Synhaeve, Martin J van den Bent, Pim J French, et al.
Plos One|June 29, 2018
IDH1-mutated transgenic zebrafish lines: An in-vivo model for drug screening and functional analysisYa Gao, Maurice de Wit, Eduard A Struys, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
Neuro-Oncology|February 19, 2015
Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomasMartin J van den Bent, Ya Gao, Melissa Kerkhof, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2011
A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951Martin J van den Bent, Lonneke A Gravendeel, Thierry Gorlia, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Cancers|December 3, 2020
Beyond the Influence of <i>IDH</i> Mutations: Exploring Epigenetic Vulnerabilities in ChondrosarcomaSanne Venneker, Alwine B Kruisselbrink, Zuzanna Baranski, et al.
The Prostate|April 25, 2019
A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signalingJan M Moll, Jinpei Kumagai, Martin E van Royen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2006
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatmentMathilde C M Kouwenhoven, Johan M Kros, Pim J French, et al.
Cancer Research|June 19, 2007
Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arraysPim J French, Justine Peeters, Sebastiaan Horsman, et al.
Scientific Reports|February 21, 2020
Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumorsAzadeh Amirnasr, Robert M Verdijk, Patricia F van Kuijk, et al.
Acta Neuropathologica Communications|November 25, 2018
Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnosticsNathalie E Synhaeve, Martin J van den Bent, Pim J French, et al.
Plos One|June 29, 2018
IDH1-mutated transgenic zebrafish lines: An in-vivo model for drug screening and functional analysisYa Gao, Maurice de Wit, Eduard A Struys, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
Neuro-Oncology|February 19, 2015
Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomasMartin J van den Bent, Ya Gao, Melissa Kerkhof, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2011
A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951Martin J van den Bent, Lonneke A Gravendeel, Thierry Gorlia, et al.
Pageof 13